Skip to main content

Teladoc Health Inc(TDOC-N)

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Why Teladoc Health Was a Sickly Stock Today

Motley Fool - Wed Aug 17, 4:04PM CDT

What happened

Teladoc Health's (NYSE: TDOC) stock wasn't the picture of financial health Wednesday. Investors traded it down by nearly 9%, after an analyst dinged the shares with a recommendation downgrade.

So what

That analyst, Sandy Draper of Guggenheim, downgraded his Teladoc recommendation to sell from the previous neutral, with a price target of $25 per share. Even after Wednesday's drop, that implies more than 30% downside to the stock's level.

Draper feels that Teladoc remains overly exposed to the consumer segment, as it derives roughly 40% of its revenue from such users. A strong dollar also won't help; as a telehealth services provider, of course it's not particularly constrained by borders. As for business spending, the analyst wrote of a "challenging macro environment that is elongating sales cycles in enterprise decisions."

Teladoc is a star healthcare stock that has lost its shine. It was a hot item in the thick of the coronavirus pandemic, as telehealth solutions became a viable option in a world of shut-ins and office closures. Recent quarterly earnings disappointments compound the feeling among certain investors that the company's best days are behind it.

Now what

It's important to note, though, that Teladoc still has more than a few believers. This crowd includes a number of analysts, some of whom are unhesitatingly bullish. One is D.A. Davidson's Robert Simmons, who late last week initiated coverage of Teladoc stock with a buy recommendation at a price target of $45 per share. In a research note, Simmons opined that the scale and variety in telehealth the company has achieved will continue to power its growth in the future.

10 stocks we like better than Teladoc Health
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

They just revealed what they believe are the ten best stocks for investors to buy right now... and Teladoc Health wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of July 27, 2022

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Teladoc Health. The Motley Fool has a disclosure policy.

Paid Post: Content produced by Motley Fool. The Globe and Mail was not involved, and material was not reviewed prior to publication.